Numab
0 followers
Numab Therapeutics is an oncology-focused biopharmaceutical company based in the Zurich-area, Switzerland. At Numab, they are writing the next chapter in cancer immunotherapy by creating multi-specific antibodies that enable the pursuit of novel therapeutic strategies.
Org chart
David Urech
Chief Executive Officer
David Urech
Collapse
Sebastian Meyer
Chief Operating Officer
Roland Helfenstein
Chief Financial Officer
James Singleton
General Counsel And Board Secretary
Daniel Snell
SVP of Research & Preclinical Development
Stefan Warmuth
SVP of Technology & CMC
Tea Gunde
VP, Discovery
Taryn Losch Beridon
VP, Clinical Operations & Regulatory Affairs
Piritta Felker
Head Quality Assurance
Martin Stern
SVP Clinical Development
Ivo Grgic
Director Business Development
